Get the Stockscreener App
3.82
1.29%
-0.05
Design Therapeutics Inc stock is traded at $3.82, with a volume of 62,810.
It is down -1.29% in the last 24 hours and up +8.52% over the past month.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
See More
Previous Close:
$3.87
Open:
$3.81
24h Volume:
62,810
Relative Volume:
0.64
Market Cap:
$216.86M
Revenue:
-
Net Income/Loss:
$-66.86M
P/E Ratio:
-3.1833
EPS:
-1.2
Net Cash Flow:
$-58.82M
1W Performance:
-4.98%
1M Performance:
+8.52%
6M Performance:
-21.24%
1Y Performance:
-24.36%
1-Day Range:
$3.77
$3.915
1-Week Range:
$3.76
$4.1899
52-Week Range:
$2.60
$7.77
Design Therapeutics Inc Stock (DSGN) Company Profile
Name
Design Therapeutics Inc
Sector
Industry
Phone
858-293-4900
Address
6005 HIDDEN VALLEY ROAD, CARLSBAD
Compare DSGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DSGN
Design Therapeutics Inc
|
3.82 | 219.69M | 0 | -66.86M | -58.82M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Design Therapeutics Inc Stock (DSGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-14-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-15-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Aug-15-23 | Downgrade | SVB Securities | Outperform → Market Perform |
| Aug-15-23 | Downgrade | Wedbush | Outperform → Neutral |
| May-04-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-10-22 | Initiated | Wedbush | Outperform |
| May-02-22 | Initiated | RBC Capital Mkts | Outperform |
| Jan-19-22 | Initiated | Goldman | Sell |
| Apr-20-21 | Initiated | Goldman | Neutral |
| Apr-20-21 | Initiated | Piper Sandler | Overweight |
| Apr-20-21 | Initiated | SVB Leerink | Outperform |
View All
Design Therapeutics Inc Stock (DSGN) Latest News
What makes Design Therapeutics Inc. stock attractive to long term investorsLow-Risk Reversal Pattern Analysis Tracker - Newser
Design Therapeutics (DSGN) Expected to Announce Earnings on Monday - Defense World
How Design Therapeutics Inc. stock performs during market volatilityFree Reliable Alerts for Daily Stock Movers - Newser
How many analysts rate Design Therapeutics Inc. as a “Buy”Advanced Screener Alerts That Work - jammulinksnews.com
Has Design Therapeutics Inc. found a price floorFree Stock Selection With High Accuracy - Newser
What are the technical indicators suggesting about Design Therapeutics Inc.Free Stock Insights From AI Tools - jammulinksnews.com
Measuring Design Therapeutics Inc.’s beta against major indicesAlpha Generation Strategy with Low Volatility - Newser
News impact scoring models applied to Design Therapeutics Inc.Long-Term Stock Growth Forecast Insights - Newser
Key metrics from Design Therapeutics Inc.’s quarterly dataTrend Following Ideas with Volume Confirmation - Newser
Market reaction to Design Therapeutics Inc.’s recent newsSwing Trade Entry and Exit Point Analysis - Newser
Using flow based indicators on Design Therapeutics Inc.Forecasting Stock Moves with AI Insights - Newser
Using data filters to optimize entry into Tenax Therapeutics Inc.Pattern Recognition Based Market Move Prediction - Newser
How to build a dashboard for Design Therapeutics Inc. stockTechnical Analysis of Growth Stock Opportunities - Newser
Is it the right time to buy Design Therapeutics Inc. stockExpert Picks Guidance For 2025 - jammulinksnews.com
Backtesting results for PDFS trading strategiesStock Market Trend and Pattern Analysis - Newser
What institutions are buying INEO stock nowMomentum Entry Alerts with Risk Control - Newser
Design Therapeutics Inc. Could See a Relief Rally From SupportSwing Trading Plan With Smart Signals in Review - metal.it
Price momentum metrics for Galectin Therapeutics Inc. explainedTechnical Reversal Setup with Risk Limits - Newser
Design Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayChart Pattern Strategy with ROI Focus - Newser
Evaluating Design Therapeutics Inc. with trendline analysisLow Risk Stock Trade Opportunity Analysis - Newser
Can swing trading help recover from MRVL lossesHigh Return Idea With Technical Filter - Newser
Published on: 2025-07-29 21:50:09 - metal.it
P 500Chart Scanner for Swing Trade Timing - Newser
Why XFOR stock attracts strong analyst attentionTrade Alert System with Volume Analysis - Newser
Published on: 2025-07-29 05:25:09 - Newser
What technical models suggest about Design Therapeutics Inc.’s comeback - metal.it
Trend analysis for Design Therapeutics Inc. this weekFree Wealth Building Stock Market Ideas - Newser
What Fibonacci levels say about ALEX reboundYield Curve Outlook and Long-Term Implication Summary - Newser
Technical Bounce Expected in Design Therapeutics Inc. Next WeekEntry Alert With Low Drawdown Strategy Noted - metal.it
Why Design Therapeutics Inc. stock attracts strong analyst attentionBuy Strategy Review With Performance Summary - Newser
Will AVITA Medical Inc. stock benefit from AI tech trendsDaily Breakout List with Smart Filters - Newser
Resistance Break Could Fuel Design Therapeutics Inc. RallyCommunity Shared Smart Money Signals Show Movement - metal.it
How to track smart money flows in GLSILong-Term Trend Tracking and Signal Summary - Newser
What catalysts could drive Design Therapeutics Inc. stock higher in 2025Free Stock Market Forecast Reports - jammulinksnews.com
How strong is Design Therapeutics Inc. company’s balance sheetCapitalize on momentum-driven investment opportunities - jammulinksnews.com
Design Therapeutics Inc. Company Revenue and Profit Trends: A Deep DiveShort Term High Return Strategy - Newser
Is Design Therapeutics Inc. a Top Dividend Stock to Watch in 2025Free Professional Trading Signals - Newser
Why is Design Therapeutics Inc. stock attracting strong analyst attentionUnlock exclusive trading tools and resources - jammulinksnews.com
When is Design Therapeutics Inc. stock expected to show significant growthDiscover the next big stock winners - jammulinksnews.com
What institutions are buying Kyverna Therapeutics Inc. stock nowFree Discussion Group - Newser
Is Design Therapeutics Inc. stock a growth or value playTop ROI Selections - Newser
Is Design Therapeutics Inc. a good long term investmentRapid market gains - PrintWeekIndia
What drives GH Research PLC stock priceConsistent wealth multiplication - PrintWeekIndia
Indian Stocks with Global Expansion Potential Expert Trader GroupExceptional stock performance - PrintWeekIndia
What drives Design Therapeutics Inc. stock pricePhenomenal returns - PrintWeekIndia
Design Therapeutics Faces Financial Strain Amid International Trade Challenges - TipRanks
Design Therapeutics Inc Stock (DSGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):